Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT03433118 Completed - Cancer Clinical Trials

Acupuncture in Cancer Patients Undergoing Radiotherapy Treatment

Start date: August 12, 2015
Phase: N/A
Study type: Interventional

Feasibility randomized controlled trial of standard care v standard care + acupuncture administered by specially-trained therapy radiographers in patients undergoing radiotherapy. It is a feasibility study to investigate all aspects of a future definitive randomized controlled trial, including statistical power calculation, hence there is no primary outcome or time point. Mixed methods: literature review, model validity, training and mentoring of radiographers, processes, resources, interventions, procedures, patient clinical outcomes, patient and stakeholder qualitative outcomes

NCT ID: NCT03432936 Recruiting - Cancer Clinical Trials

Prospective Use of Philips iSuite for Interventional Procedures

Start date: March 2018
Phase: N/A
Study type: Interventional

This research study is being done to look at new MRI imaging guidance software, Philips Interventional iSuite software, to see if using will improve the physician's ability to quickly place and guide needle tip position for biopsies and ablations.

NCT ID: NCT03431948 Not yet recruiting - Cancer Clinical Trials

Stereotactic Body Radiotherapy (SBRT) Plus Immunotherapy for Cancer

Start date: February 2018
Phase: Phase 1
Study type: Interventional

Study to determine the best dose of stereotactic body radiation therapy (SBRT) to be administered in combination with immunotherapy drugs including urelumab, cabiralizumab and nivolumab .

NCT ID: NCT03430141 Recruiting - Cancer Clinical Trials

A Nutritarian Study to Evaluate the Effectiveness of Lifestyle Changes in Chronic Disease Prevention, Especially Cancer

Start date: October 31, 2016
Phase: N/A
Study type: Interventional

The Nutritarian Women's Health Study (NWHS) is a long-term hybrid effectiveness-implementation study on the effect of the Nutritarian Diet on the occurrence, recurrence, and progression of chronic diseases (including all forms of cancer and cardiometabolic risk factors).

NCT ID: NCT03426488 Recruiting - Cancer Clinical Trials

Northern Sweden Health and Disease Study

Start date: January 1986
Phase: N/A
Study type: Observational

NSHDS (Northern Sweden Health and Disease Study) is an umbrella term for a prospective biobank with related survey data. The sample collection consists of three subcohorts, Västerbotten Intervention Programme (VIP), Mammography Screening Project (MA) and MONICA (MONItoring of Trends and Determinants in CArdiovascular Disease). The blood samples are stored at the Northern Sweden Biobank.

NCT ID: NCT03424512 Not yet recruiting - Depression Clinical Trials

Group Metacognitive Therapy for Anxiety and Depression in Cancer Survivors

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

This study aims to test the potential of group metacognitive therapy in alleviating emotional distress in cancer survivors. The investigators aim to find out if a group based approach is acceptable to patients and feasible to deliver in a routine clinical health psychology service.

NCT ID: NCT03419455 Active, not recruiting - Obesity Clinical Trials

Diet, Adiposity, and Metabolic Alterations

Start date: January 2017
Phase: N/A
Study type: Observational

Obesity is associated with increased risk of several cancers. Suggested mechanisms mediating the obesity-cancer associations include hyperinsulinemia and altered IGF signaling, changes in sex hormone levels as well as altered secretion of adipokines and inflammatory proteins. However, little is known about the influence of lifetime adiposity on the relevant biomarkers. Moreover, although diet has been suggested to ameliorate the adverse metabolic effects of obesity, convincing evidence regarding how dietary factors may influence obesity-related carcinogenic pathways remains lacking. Thus, in the current project, the investigators aim to 1) examine the associations between trajectories of body fatness and plasma biomarker levels of the insulin/IGF system, sex hormones and biomarkers of inflammatory response including adipokines; 2) investigate how nutritional factors may modulate these obesity-related biomarkers. The investigators propose to utilize two large ongoing cohorts of US men and women, the Nurses' Health Study and Health Professionals Follow-up Study.

NCT ID: NCT03415139 Not yet recruiting - Cancer Clinical Trials

Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant

Start date: July 2018
Phase: N/A
Study type: Observational

This clinical research studies the physiology and immunology of new-onset post-transplant diabetes mellitus in patients undergoing allogeneic stem cell transplantation. Oral glucose tolerance tests (OGTT), hyperglycemic clamps, and immune assays will be used to define the mechanisms associated with abnormal glucose homeostasis following stem cell transplantation. Information from this clinical trial could be used to develop standardized screening procedures or to develop optimal treatment strategies for patients developing post-transplant diabetes mellitus.

NCT ID: NCT03415126 Recruiting - Cancer Clinical Trials

A Study of ASN007 in Patients With Advanced Solid Tumors

Start date: January 19, 2018
Phase: Phase 1
Study type: Interventional

The study is divided into two parts. The first part of the study will test various doses of ASN007 to find out the highest safe dose to test in five specific groups. The second part of the study will test how well ASN007 can control cancer.

NCT ID: NCT03412344 Recruiting - Cancer Clinical Trials

Factors Influencing Cancer Patients Participation in Clinical Trials in China.

Start date: July 15, 2017
Phase: N/A
Study type: Observational

This research studies factors affecting Chinese patient participation in cancer clinical trials and their knowledge regarding clinical trials. The investigators design this study to determining how patients makes decisions about participating in a clinical trial and know about patients' attitude toward clinical trials. The investigators aim to find ways to make cancer clinical trials in China more efficient and satisfied patients participating in clinical trials in China.